Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope

JW Groothoff, E Metry, L Deesker, S Garrelfs… - Nature Reviews …, 2023 - nature.com
Primary hyperoxaluria (PH) is an inherited disorder that results from the overproduction of
endogenous oxalate, leading to recurrent kidney stones, nephrocalcinosis and eventually …

Genetic assessment in primary hyperoxaluria: why it matters

G Mandrile, B Beck, C Acquaviva, G Rumsby… - Pediatric …, 2023 - Springer
Accurate diagnosis of primary hyperoxaluria (PH) has important therapeutic consequences.
Since biochemical assessment can be unreliable, genetic testing is a crucial diagnostic tool …

Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trial

W Hayes, DJ Sas, D Magen, H Shasha-Lavsky… - Pediatric …, 2023 - Springer
Background Primary hyperoxaluria type 1 (PH1) is a rare genetic disease that causes
progressive kidney damage and systemic oxalosis due to hepatic overproduction of oxalate …

Isolated kidney transplantation under lumasiran therapy in primary hyperoxaluria type 1: a report of five cases

AL Sellier-Leclerc, E Metry, S Clave… - Nephrology Dialysis …, 2023 - academic.oup.com
Primary hyperoxaluria type 1 (PH1) is caused by a mutation in the AGXT gene, encoding the
hepatic peroxisomal enzyme alanine-glyoxylate aminotransferase (AGT). Defects in AGT …

Primary hyperoxaluria: Comprehensive mutation screening of the disease causing genes and spectrum of disease‐associated pathogenic variants

A Abid, A Raza, AR Khan, S Firasat, S Shahid… - Clinical …, 2023 - Wiley Online Library
The primary hyperoxalurias are rare disorders of glyoxylate metabolism. Accurate diagnosis
is essential for therapeutic and management strategies. We conducted a molecular study on …

The role of genetic testing in the diagnostic workflow of pediatric patients with kidney diseases: the experience of a single institution

T Vaisitti, V Bracciamà, AC Faini, GM Brach Del Prever… - Human Genomics, 2023 - Springer
Purpose Inherited kidney diseases are among the leading causes of kidney failure in
children, resulting in increased mortality, high healthcare costs and need for organ …

Primary hyperoxaluria type 1 in children: clinical and laboratory manifestations and outcome

H Wannous - Pediatric Nephrology, 2023 - Springer
Background Primary hyperoxaluria (PH) results from genetic mutations in different genes of
glyoxylate metabolism, which cause significant increases in production of oxalate by the …

The treatment of biochemical genetic diseases: From substrate reduction to nucleic acid therapies

EN Vos, D Demirbas, M Mangel… - Molecular Genetics and …, 2023 - Elsevier
Newborn screening (NBS) began a revolution in the management of biochemical genetic
diseases, greatly increasing the number of patients for whom dietary therapy would be …

Primary hyperoxaluria: the pediatric nephrologist's point of view

E Ben-Shalom, SF Garrelfs… - Clinical Kidney …, 2022 - academic.oup.com
The clinical presentation of primary hyperoxaluria in children ranges from mildly
symptomatic nephrocalcinosis to very early onset end-stage kidney failure with systemic …

Lumasiran: expanding the treatment options for patients with primary hyperoxaluria type 1

SA Hulton - Expert Opinion on Orphan Drugs, 2021 - Taylor & Francis
Introduction Primary hyperoxaluria type 1 (PH1) is an inborn error of glyoxylate metabolism
whereby excessive endogenous oxalate production can result in kidney failure, systemic …